Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AstraZeneca Launches Crestor In Canada At 15% Discount To Lipitor

Executive Summary

AstraZeneca is launching its lipid lowering drug Crestor in Canada at a 15% discount to Pfizer's Lipitor

You may also be interested in...



AstraZeneca Crestor Pricing On Par With Lipitor; Pattern Could Repeat In U.S.

AstraZeneca is unlikely to seek a premium price for Crestor when it is launched in the U.S., CEO Tom McKillop indicated on a July 24 earnings call

AstraZeneca Crestor Pricing On Par With Lipitor; Pattern Could Repeat In U.S.

AstraZeneca is unlikely to seek a premium price for Crestor when it is launched in the U.S., CEO Tom McKillop indicated on a July 24 earnings call

AstraZeneca Crestor 10 mg Fixed Starting Dose Supported By Committee

Dosing for AstraZeneca's statin Crestor in the general population should start with a fixed dose of 10 mg, FDA's Endocrinologic & Metabolic Drugs Advisory Committee recommended July 9

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS041300

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel